Aurinia Pharmaceuticals Inc - Common Shares
30-Day Trend
AUPH (Aurinia Pharmaceuticals Inc - Common Shares) is ranked #77 on the All Score across StockTwits, Korea, China, Germany, and Japan retail investor sources.
Aurinia Pharmaceuticals (AUPH) Tops Q3 Earnings Estimates
Yahoo · Oct 30, 2026
Aurinia: Q3 Earnings Snapshot
Yahoo · Oct 30, 2026
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2026 and Provides Update on Recent Business Progress
Yahoo · Oct 30, 2026
Aurinia Pharmaceuticals Raises FY2026 Sales Guidance from $315.000M-$325.000M to $325.000M-$330.000M vs $330.261M Est
Benzinga · Oct 30, 2026
Aurinia Pharmaceuticals Q3 EPS $0.23 Beats $0.22 Estimate, Sales $83.699M Beat $83.691M Estimate
Benzinga · Oct 30, 2026
US market headlines from third-party sources. Updated daily.
Updated
